Quantcast

Jewish Journal

‘Star Trek’ star Leonard Nimoy ‘doing OK’ after lung disease diagnosis

Reuters

February 7, 2014 | 12:13 am

Leonard Nimoy in Hollywood on May 14, 2013.Photo by Fred Prouser/Reuters

Leonard Nimoy in Hollywood on May 14, 2013.Photo by Fred Prouser/Reuters

Veteran actor Leonard Nimoy, best known as Spock in the 1960s television series "Star Trek" and a string of feature films that followed, said he was "doing OK" after being diagnosed with lung disease and urged fans on Thursday to quit smoking.

"Smokers, please understand. If you quit after you're diagnosed with lung damage it's too late. Grandpa says learn my lesson. Quit now," Nimoy tweeted to his 810,000 followers.

In Nimoy's case, the actor said, he was diagnosed despite having quit smoking 30 years ago.

The 82-year-old actor added he was "doing OK. Just can't walk distances," and he signed off with "LLAP," an abbreviation of his character's trademark phrase, "live long and prosper."

Nimoy first revealed in a Twitter message posted last week that he has chronic obstructive pulmonary disease, or COPD, a severe lung ailment that the U.S. surgeon general has concluded is linked to smoking.

Representatives for the actor did not immediately respond to Reuters' request for further comment.

Nimoy, a native of Boston, has become synonymous with his role as Spock, the fictional half-human, half-Vulcan first officer and later commander of the starship Enterprise, in the television and film versions of "Star Trek."

He most recently appeared in J.J. Abrams' "Star Trek Into Darkness" last year, and is a celebrated figure among the franchise's loyal and avid fan base.

Reporting by Piya Sinha-Roy; Editing by Steve Gorman and Andre Grenon

Tracker Pixel for Entry

COMMENTS

We welcome your feedback.

Privacy Policy

Your information will not be shared or sold without your consent. Get all the details.

Terms of Service

JewishJournal.com has rules for its commenting community.Get all the details.

Publication

JewishJournal.com reserves the right to use your comment in our weekly print publication.